FY2022 · ended Sep 30, 2022 · Revenue $2.70M, +7.8% YoY · Filed Jan 19, 2024
Hypha Labs, Inc. (FUNI) files with the SEC under industry code 8734, Services-Testing Laboratories. Free cash flow was -$412,941. As of Jun 30, 2026 it held $5,110 in cash and investments and $1.8 million in total debt.
Revenue (TTM)
$2.73M
+0.9% vs year-ago TTM
Net income (TTM)
$-2.02M
-252.2% vs year-ago TTM
Operating cash flow (TTM)
$-568,055
-13.4% vs year-ago TTM
Free cash flow
$-412,941
+61.1% vs prior year
EPS
$-0.02
-100.0% vs prior year
Dividend per share
None
Shares outstanding
155.52M
+22.9% vs prior year
Net cash
$-1.83M
as of Jun 30, 2026
Operating margin
-38.1%
FY 2023
Company profile
- Industry
- Services-Testing Laboratories (SIC 8734)
- Listed as
- FUNI (OTC)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1502966
- Former names
- Digipath, Inc. (until Mar 1, 2024); DigiPath,Inc. (until Sep 18, 2018)
Other Services-Testing Laboratories companies
- UL Solutions Inc. ULS
- Neogenomics Inc NEO
- 20/20 Biolabs, Inc. AIDX
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Sep 30, 2025 |
FY 2024 Sep 30, 2024 |
FY 2023 Sep 30, 2023 |
FY 2022 Sep 30, 2022 |
FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $2.7M | $2.5M |
| Operating income | -$3.0M | -$1.8M | -$437,388 | -$1.2M | -$772,448 |
| Net income | -$3.1M | -$785,429 | $246,774 | -$2.1M | -$686,503 |
| Diluted EPS | -$0.02 | -$0.01 | $0.00 | — | — |
| Operating cash flow | -$379,975 | -$1.0M | $112,525 | -$184,786 | -$135,968 |
| Free cash flow | -$412,941 | -$1.1M | — | -$202,508 | -$192,174 |
| Total assets | $409,218 | $493,805 | $1.4M | $1.3M | $1.9M |
| Total liabilities | $2.5M | $1.4M | $3.3M | $3.7M | $2.9M |
| Stockholders' equity | -$2.4M | -$1.3M | -$2.2M | -$2.7M | -$1.1M |
| Cash and investments | $38,118 | $91,166 | $271,006 | $56,168 | $295,932 |
| Total debt | $26,838 | $63,266 | — | $330,510 | $444,131 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Feb 17, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Auditor change
|
Jan 30, 2026 | Jan 27, 2026 |
| 10-K | Annual report | Jan 15, 2026 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 21, 2025 | Jun 30, 2025 |
All 297 Hypha Labs, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.